These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8317922)

  • 1. Characterization of two structurally novel HIV-1 protease inhibitors identified by rational selection.
    Humblet CC; Lunney EA; Buckheit RW; Doggett C; Wong R; Antonucci TK
    Antiviral Res; 1993 May; 21(1):73-84. PubMed ID: 8317922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 protease as a therapeutic target for AIDS.
    Debouck C
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):153-64. PubMed ID: 1540403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of HIV-1 protease.
    Meek TD
    J Enzyme Inhib; 1992; 6(1):65-98. PubMed ID: 1285304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ultrasensitive human immunodeficiency virus type 1 protease radioimmuno rate assay with a potential for monitoring blood levels of protease inhibitors in acquired immunodeficiency disease syndrome patients.
    Evans DB; Vosters AF; McQuade TJ; Sharma SK
    Anal Biochem; 1992 Nov; 206(2):288-92. PubMed ID: 1443599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro.
    McPhee F; Caldera PS; Bemis GW; McDonagh AF; Kuntz ID; Craik CS
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):681-6. PubMed ID: 8973584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A symmetric inhibitor binds HIV-1 protease asymmetrically.
    Dreyer GB; Boehm JC; Chenera B; DesJarlais RL; Hassell AM; Meek TD; Tomaszek TA; Lewis M
    Biochemistry; 1993 Jan; 32(3):937-47. PubMed ID: 8422397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational approach in the search for potent inhibitors against HIV proteinase.
    Hui KY; Manetta JV; Gygi T; Bowdon BJ; Keith KA; Shannon WM; Lai MH
    FASEB J; 1991 Aug; 5(11):2606-10. PubMed ID: 1868985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.
    Young SD; Payne LS; Thompson WJ; Gaffin N; Lyle TA; Britcher SF; Graham SL; Schultz TH; Deana AA; Darke PL
    J Med Chem; 1992 May; 35(10):1702-9. PubMed ID: 1588552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV protease and therapies for AIDS.
    Korant BD; Rizzo CJ
    Adv Exp Med Biol; 1997; 421():279-84. PubMed ID: 9330709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.
    Nagarajan SR; De Crescenzo GA; Getman DP; Lu HF; Sikorski JA; Walker JL; McDonald JJ; Houseman KA; Kocan GP; Kishore N; Mehta PP; Funkes-Shippy CL; Blystone L
    Bioorg Med Chem; 2003 Nov; 11(22):4769-77. PubMed ID: 14556792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.
    Bouzide A; Sauvé G; Yelle J
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1509-13. PubMed ID: 15713418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):865-72. PubMed ID: 1445327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.
    Voshavar C
    Curr Top Med Chem; 2019; 19(18):1571-1598. PubMed ID: 31237209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV protease: a novel chemotherapeutic target for AIDS.
    Huff JR
    J Med Chem; 1991 Aug; 34(8):2305-14. PubMed ID: 1875332
    [No Abstract]   [Full Text] [Related]  

  • 19. Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323.
    Erickson-Viitanen S; Klabe RM; Cawood PG; O'Neal PL; Meek JL
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1628-34. PubMed ID: 7979296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statine based tripeptides as potent inhibitors of HIV-1 replication.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):873-8. PubMed ID: 1445328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.